Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype. (Q53464183)

14 May 2018

title

Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype. (English)

1 reference

14 May 2018

author

Juhani Knuuti

9

1 reference

14 May 2018

author name string

Ilveskoski E

1

1 reference

14 May 2018

Lehtimäki T

2

1 reference

14 May 2018

Laaksonen R

3

1 reference

14 May 2018

Janatuinen T

4

1 reference

14 May 2018

Vesalainen R

5

1 reference

14 May 2018

Nuutila P

6

1 reference

14 May 2018

Laippala P

7

1 reference

14 May 2018

Karhunen PJ

8

1 reference

14 May 2018

publication date

1 January 2007

1 reference

14 May 2018

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

14 May 2018

volume

67

1 reference

14 May 2018

issue

7

1 reference

14 May 2018

page(s)

723-734

1 reference

14 May 2018

Atherosclerosis — An Inflammatory Disease

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Early impairment of coronary flow reserve in young men with borderline hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Coronary flow reserve is reduced in young men with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Coronary flow reserve in young men with familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Apolipoprotein E4: an allele associated with many diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Effects of adenosine on human coronary arterial circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

Apolipoprotein E Alleles and Risk of Coronary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701297472

10.1080/00365510701297472

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018